Target intelligence / Profile preview

BCL2 interacting protein 3 pseudogene 17 (BNIP3P17)

Target: BNIP3P17
Molecular classification: Other (Pseudogene)[4]

Overview

BCL2 interacting protein 3 pseudogene 17 (BNIP3P17) is a non-coding pseudogene found in the human genome[4]. It does not produce a functional protein and is not considered a therapeutic target. No molecular function, disease association, or drug interaction is established for this pseudogene. Its nomenclature and annotation are based on its sequence similarity to the protein-coding BNIP3 gene, but as a pseudogene, it is not involved in biological pathways, disease mechanisms, or therapeutic contexts[4].

Other names: BCL2/adenovirus E1B 19kDa interacting protein 3 pseudogene 17BNIP3P17[4]

Beyond the preview

Go deeper on BCL2 interacting protein 3 pseudogene 17 (BNIP3P17).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on BCL2 interacting protein 3 pseudogene 17 (BNIP3P17).

Explore the full profile